Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature

References

• Iaria G, Pisani F, Iorio B et al. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression. Transplant. Proc. 38(4), 1018–1019 (2006).
   Google Scholar
• Salvadori M, Scolari MP, Bertoni E et al. Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. Transplantation 88(10), 1194–1202 (2009).
   PubMed Web of Science ®Google Scholar
• Iaria G, Anselmo A, De Luca L et al. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: case reports. Transplant. Proc. 39(6), 2036–2037 (2007).
   Web of Science ®Google Scholar
• Manuelli M, De Luca L, Iaria G et al. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation. Transplant. Proc. 42(4), 1314–1316 (2010).
   Google Scholar
• Manzia TM, Bellini MI, Corona L et al. Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Transpl. Int. 24(8), e69–70 (2011).
   PubMed Web of Science ®Google Scholar
• White PS, Swindells DCN. Acta Crytallogr. A (Volume 37). C75 (1981).
   Google Scholar
• Sedrani R, Cottens S, Kallen J, Schuler W. Chemical modification of rapamycin: the discovery of SDZ RAD. Transplant. Proc. 30(5), 2192–2194 (1998).
   PubMed Web of Science ®Google Scholar
• Bererhi L, Flamant M, Martinez F, Karras A, Thervet E, Legendre C. Rapamycin induced oligospermia. Transplantation 76(5), 885–886 (2003).
   PubMed Web of Science ®Google Scholar
• Kaczmarek I, Groetzner J, Adamidis I et al. Sirolimus impairs gonadal function in heart transplant recipients. Am. J. Transplant. 4(7), 1084–1088 (2004).
   PubMed Web of Science ®Google Scholar
• Fritsche L, Budde K, Dragun D, Einecke G, Diekmann F, Neumayer HH. Testosterone concentrations and sirolimus in male renal transplant patients. Am. J. Transplant. 4(1), 130–131 (2004).
   PubMed Web of Science ®Google Scholar
• Tondolo V, Citterio F, Panocchia N et al. Gonadal function and immunosuppressive therapy after renal transplantation. Transplant. Proc. 37(4), 1915–1917 (2005).
   PubMed Web of Science ®Google Scholar
• Lee S, Coco M, Greenstein SM, Schechner RS, Tellis VA, Glicklich DG. The effect of sirolimus on sex hormone levels of male renal transplant recipients. Clin. Transplant. 19(2), 162–167 (2005).
   PubMed Web of Science ®Google Scholar
• Skrzypek J, Krause W. Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment. Andrologia 39(5), 198–199 (2007).
   PubMed Web of Science ®Google Scholar
• Deutsch MA, Kaczmarek I, Huber S et al. Sirolimus associated infertility: case report and literature review of possible mechanisms. Am. J. Transplant. 7(10), 2414–2421 (2007).
   PubMed Web of Science ®Google Scholar
• Zuber J, Anglicheau D, Elie C et al. Sirolimus may reduce fertility in male renal transplant recipients. Am. J. Transplant. 8(7), 1471–1479 (2008).
   PubMed Web of Science ®Google Scholar
• Boobes Y. Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus. Int. Urol. Nephrol. 42(2), 493–498 (2010).
   PubMed Web of Science ®Google Scholar
• Rovira J, Diekmann F, Ramírez-Bajo MJ, Bañón-Maneus E, Moya-Rull D, Campistol JM. Sirolimus-associated testicular toxicity: detrimental but reversible. Transplantation 93(9), 874–879 (2012).
   PubMed Web of Science ®Google Scholar
• Yu J, Yaba A, Kasiman C, Thomson T, Johnson J. mTOR controls ovarian follicle growth by regulating granulosa cell proliferation. PLoS ONE 6(7), e21415 (2011).
   PubMed Web of Science ®Google Scholar
• EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipients. IV.10. Pregnancy in renal transplant recipients. Nephrol. Dial. Transplant. 17(Suppl 4), 50–55 (2002).
   PubMedGoogle Scholar
• Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet. Gynecol. 103(5 Pt 2), 1091–1094 (2004).
   PubMed Web of Science ®Google Scholar
• Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82(12), 1698–1702 (2006).
   PubMed Web of Science ®Google Scholar
• Perez-Aytes A, Ledo A, Boso V et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am. J. Med. Genet. A. 146A(1), 1–7 (2008).
   PubMed Web of Science ®Google Scholar
• Framarino dei Malatesta M, Rocca B, Gentile T et al. A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. Transpl. Proc. 41(4), 1407–1409 (2009).
   Google Scholar
• Mauduit C, Hamamah S, Benahmed M. Stem cell factor/c-kit system in spermatogenesis. Hum. Reprod. Update. 5(5), 535–545 (1999).
   PubMed Web of Science ®Google Scholar
• Feng LX, Ravindranath N, Dym M. Stem cell factor/c-kit upregulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia. J. Biol. Chem. 275(33), 25572–25576 (2000).
   PubMed Web of Science ®Google Scholar
• Walensky LD, Dawson TM, Steiner JP et al. The 12 kD FK 506 binding protein FKBP12 is released in the male reproductive tract and stimulates sperm motility. Mol. Med. 4(8), 502–514 (1998).
   PubMed Web of Science ®Google Scholar
• Sosnowski R, Mellon PL, Lawson MA. Activation of translation in pituitary gonadotrope cells by gonadotropinreleasing hormone. Mol. Endocrinol. 14(11), 1811–1819 (2000).
   PubMedGoogle Scholar
• Jankowska I, Oldakowska-Jedynak U, Jabiry-Zieniewicz Z et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant. Proc. 36(10), 3232–3233 (2004).
   PubMed Web of Science ®Google Scholar
• Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82(12), 1698–1702 (2006).
   PubMed Web of Science ®Google Scholar
• Guardia O, Rial MC, Casadei D. Pregnancy under sirolimus-based immunosuppression. Transplantation 81(4), 636 (2006).
   PubMed Web of Science ®Google Scholar
• Chu SH, Liu KL, Chiang YS, Wang HH, Lai PC. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transpl. Proc. 40(7), 2446–2448 (2008).
   PubMed Web of Science ®Google Scholar
• Framarino dei Malatesta M, Corona LE, De Luca L et al. Succesfull pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. Transplantation 91(9), 69–71 (2011).
   PubMed Web of Science ®Google Scholar
• Veroux M, Corona D, Veroux P. Pregnancy under everolimus-based immunosuppression. Transpl. Int. 24(12), e115–117 (2011).
   PubMed Web of Science ®Google Scholar
• Carta P, Caroti L, Zanazzi M. Pregnancy in a kidney transplant patient treated with everolimus. Am. J. Kidney. Dis. 60(2), 329 (2012).
   PubMed Web of Science ®Google Scholar
• Lager S, Powell TL. Regulation of nutrient transport across the placenta. J. Pregnancy. doi:10.1155/2012/179827 (2012) (Epub ahead of print).
   Google Scholar
• Kahan BD, Podbielski J, Napoli KL, Katz SM, Meier-Kriesche HU, Van Buren CT. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renaltransplantation. Transplantation 66(8), 1040–1046 (1998).
   PubMed Web of Science ®Google Scholar
• Hoogeveen RC, Ballantyne CM, Pownall HJ et al. Effect of sirolimus on the metabolism of apoB100-containing lipoproteins in renal transplant patients. Transplantation 72(7), 1244–1250 (2001).
   PubMed Web of Science ®Google Scholar
• Morrisett JD, Abdel-Fattah G, Hoogeveen R et al. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J. Lipid Res. 43(8), 1170–1180 (2002).
   PubMed Web of Science ®Google Scholar
• Houde VP, Brûlé S, Festuccia WT et al. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59(6), 1338–1348 (2010).
   PubMed Web of Science ®Google Scholar
• Claes K, Meier-Kriesche HU, Schold JD et al. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol. Dial. Transplant 27(2), 850–857 (2012).
   PubMed Web of Science ®Google Scholar
• Vigano M, Tuzcu M, Benza R et al. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis. J. Heart Lung Transplant 26(6), 584–592 (2007).
   PubMed Web of Science ®Google Scholar
• Zortress®, package insert. Novartis Pharmaceuticals, NJ, USA.
   Google Scholar
• Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 19(1), 13–22 (2002).
   PubMed Web of Science ®Google Scholar
• Roos S, Lagerlöf O, Wennergren M, Powell TL, Jansson T. Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signalling. Am. J. Physiol. Cell Physiol. 297(3), C723–731 (2009).
   Google Scholar
• Blagosklonny MV. Rapamycin-induced glucose intolerance: hunger or starvation diabetes. Cell Cycle. 10(24), 4217–4224 (2011).
   PubMed Web of Science ®Google Scholar
• Lamming DW, Ye L, Katajisto P et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335(6076), 1638–1643 (2012).
   PubMed Web of Science ®Google Scholar
• Pereira MJ, Palming J, Rizell M et al. mTOR inhibition with rapamycin causes impaired insulin signaling and glucose uptake in human subcutaneous and omental adipocytes. Mol. Cell. Endocrinol. 355(1), 96–105 (2012).
   PubMed Web of Science ®Google Scholar
• Nash B, Citterio F. Wound healing complications and the use of Mammalian Target of Rapamycin Inhibitors in kidney transplantation: a critical review of the literature. Transplantatio 94(6), 547–561 (2012).
   Google Scholar
• Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod. Sci. 16(5), 431–437 (2009).
   PubMed Web of Science ®Google Scholar
• Srivastava A, Muruganandham K, Vinodh PB et al. Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs m-TOR inhibitors. Int. Urol. Nephrol. 42(2), 279–284 (2010).
   PubMed Web of Science ®Google Scholar
• Kuppahally S, Al-Khaldi A, Weisshaar D et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetilbased regimen in cardiac transplant recipients. Am. J. Transplant. 6(5 Pt 1), 986–992 (2006).
   PubMed Web of Science ®Google Scholar
• Kobashigawa JA, Miller LW, Russell SD et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs cyclosporine with MMF in cardiac transplant patients: 1-year report. Am. J. Transplant 6(6), 1377–1386 (2006).
   PubMed Web of Science ®Google Scholar
• Dean PG, Lund WJ, Larson TS et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 77(10), 1555–1561 (2004).
   PubMed Web of Science ®Google Scholar
• Flechner SM, Zhou L, Derweesh I et al. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation 76(12), 1729–1734 (2003).
   PubMed Web of Science ®Google Scholar
• Valente JF, Hricik D, Weigel K et al. Comparison of sirolimus vs mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am. J. Transplant. 3(9), 1128–1134 (2003).
   PubMed Web of Science ®Google Scholar
• Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod. Sci. 16(5), 431–437 (2009).
   PubMed Web of Science ®Google Scholar